{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:06:49Z","timestamp":1790946409387,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00647","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T07:05:42Z","timestamp":1560236742000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Myricetin Attenuated Diabetes-Associated Kidney Injuries and Dysfunction via Regulating Nuclear Factor (Erythroid Derived 2)-Like 2 and Nuclear Factor-\u03baB Signaling"],"prefix":"10.3389","volume":"10","author":[{"given":"Zi-Jun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Iin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Han","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.2337\/db18-0124","article-title":"Histone H3 serine 10 phosphorylation facilitates endothelial activation in diabetic kidney disease","volume":"67","author":"Alghamdi","year":"2018","journal-title":"Diabetes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1042\/CS20150436","article-title":"Nrf2 in health and disease: current and future clinical implications","volume":"129","author":"Al-Sawaf","year":"2015","journal-title":"Clin. Sci. (Lond)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/13510002.2017.1297885","article-title":"Natural antioxidants in the treatment and prevention of diabetic nephropathy: a potential approach that warrants clinical trials","volume":"22","author":"Al-Waili","year":"2017","journal-title":"Redox Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2013.01.008","article-title":"Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation","volume":"57","author":"Bai","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"F348","DOI":"10.1152\/ajprenal.00568.2012","article-title":"Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK)","volume":"304","author":"Chang","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"821936","DOI":"10.1155\/2012\/821936","article-title":"Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation","volume":"2012","author":"Cui","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1152\/ajpendo.00430.2012","article-title":"Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice","volume":"304","author":"Cui","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneph.2016.170","article-title":"Renal, metabolic and cardiovascular considerations of SGLT2 inhibition","volume":"13","author":"DeFronzo","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jsfa.5733","article-title":"Myricetin attenuates lipopolysaccharide-stimulated activation of mouse bone marrow-derived dendritic cells through suppression of IKK\/NF-kappaB and MAPK signalling pathways","volume":"93","author":"Fu","year":"2013","journal-title":"J. Sci. Food Agric."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600392","article-title":"The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice","volume":"61","author":"Geng","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.bbamcr.2018.04.011","article-title":"MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease","volume":"1865","author":"Guo","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/nu9040358","article-title":"Dietary metabolites and chronic kidney disease","volume":"9","author":"Hasegawa","year":"2017","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1080\/13880209.2016.1275704","article-title":"Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice","volume":"55","author":"Hassan","year":"2017","journal-title":"Pharm. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0140-6736(93)92876-U","article-title":"Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study","volume":"342","author":"Hertog","year":"1993","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/ars.2016.6664","article-title":"Diabetes and kidney disease: role of oxidative stress","volume":"25","author":"Jha","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"B16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2337\/db09-1342","article-title":"The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy","volume":"59","author":"Jiang","year":"2010","journal-title":"Diabetes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2014.09.014","article-title":"Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy","volume":"743","author":"Kandasamy","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3671751","DOI":"10.1155\/2017\/3671751","article-title":"Prevention of streptozotocin-induced diabetic nephropathy by MG132: possible roles of Nrf2 and IkappaB","volume":"2017","author":"Kong","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/13543784.2017.1293039","article-title":"Novel avenues for treating diabetic nephropathy: new investigational drugs","volume":"26","author":"Lacava","year":"2017","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1159\/000479212","article-title":"Crocin protects podocytes against oxidative stress and inflammation induced by high glucose through inhibition of NF-kappaB","volume":"42","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"8370593","DOI":"10.1155\/2017\/8370593","article-title":"Myricetin possesses potential protective effects on diabetic cardiomyopathy through inhibiting IkappaBalpha\/NFkappaB and enhancing Nrf2\/HO-1","volume":"2017","author":"Liao","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/cr.2011.199","article-title":"The E3 ubiquitin ligase MIB1 negatively regulates basal IkappaBalpha level and modulates NF-kappaB activation","volume":"22","author":"Liu","year":"2012","journal-title":"Cell Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1089\/ars.2016.6661","article-title":"Canonical transient receptor potential 6 channel: a new target of reactive oxygen species in renal physiology and pathology","volume":"25","author":"Ma","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"B24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-62703-119-6_3","article-title":"Designing functional siRNA with reduced off-target effects","volume":"942","author":"Naito","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"F1060","DOI":"10.1152\/ajprenal.00251.2015","article-title":"Double transduction of a Cre\/LoxP lentiviral vector: a simple method to generate kidney cell-specific knockdown mice","volume":"309","author":"Nam","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/13543784.2016.1196184","article-title":"Targeting inflammation in diabetic kidney disease: early clinical trials","volume":"25","author":"Perez-Gomez","year":"2016","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/mnfr.201200563","article-title":"Microarray and pathway analysis highlight Nrf2\/ARE-mediated expression profiling by polyphenolic myricetin","volume":"57","author":"Qin","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/ki.2013.248","article-title":"Role of Nrf2 in protection against acute kidney injury","volume":"84","author":"Shelton","year":"2013","journal-title":"Kidney Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1042\/CS20160636","article-title":"Diabetic nephropathy\u2014Is this an immune disorder","volume":"131","author":"Tesch","year":"2017","journal-title":"Clin. Sci. (Lond)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/13543784.2016.1201062","article-title":"Current and investigational drugs for the treatment of diabetic retinopathy","volume":"25","author":"Tolentino","year":"2016","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"B32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jff.2015.09.009","article-title":"Polyphenol-rich propolis extracts from China and Brazil exert anti-inflammatory effects by modulating ubiquitination of TRAF6 during the activation of NF-\u03baB","volume":"19","author":"Wang","year":"2015","journal-title":"J. Funct. Foods"},{"key":"B33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/heartjnl-2017-311448","article-title":"Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting","volume":"104","author":"Wilson","year":"2018","journal-title":"Heart"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1007\/s00125-016-3958-8","article-title":"C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21","volume":"59","author":"Wu","year":"2016","journal-title":"Diabetologia"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/nu8120799","article-title":"Regressive effect of myricetin on hepatic steatosis in mice fed a high-fat diet","volume":"8","author":"Xia","year":"2016","journal-title":"Nutrients"},{"key":"B36","doi-asserted-by":"publisher","first-page":"W130","DOI":"10.1093\/nar\/gkh366","article-title":"siRNA Selection Server: an automated siRNA oligonucleotide prediction server","volume":"32","author":"Yuan","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1530\/JME-17-0260","article-title":"SP600125 suppresses Keap1 expression and results in NRF2-mediated prevention of diabetic nephropathy","volume":"60","author":"Zhang","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1039\/C6FO00825A","article-title":"Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway","volume":"7","author":"Zhang","year":"2016","journal-title":"Food Funct."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.2337\/db11-0807","article-title":"Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy","volume":"60","author":"Zheng","year":"2011","journal-title":"Diabetes"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T07:05:43Z","timestamp":1560236743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":39,"alternative-id":["10.3389\/fphar.2019.00647"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00647","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"article-number":"647"}}